Javascript must be enabled to continue!
GW24-e3077 Inhibition of PICK1 has the Protective Effect on Adriamycin-induced Toxic Myocarditis
View through CrossRef
Objectives
Adriamycin (ADR) has broad-spectrum effect such as anti-tumour and antibiotic, but it is limited the application for its dose-dependent cardiac toxicity. PICK1 is the interaction protein of PKC, which has been suggested as a potential drug target against brain ischaemia, pain and cocaine addiction. Our previous study has shown that the expression of PICK1 has increased in ADR-induced toxic myocarditis. In this study, the possible protect effect of FSC231, the specifical PDZ domain inhibitor of PICK1, against ADR-induced toxic myocarditis were carried out.
Methods
An experimental ADR-induced toxic myocarditis model was induced by intraperitoneal injection of ADR (3mg/kg) one day intervals on 14 consecutive days in mice. FSC231 (0.1ml/10g, 25 μM) was administrated by intraperitoneal injection on 14 consecutive days. At the end of the experiment, mice were sacrificed and their hearts were harvested for marker enzyme, histologic and molecular biologic analysis. The expression of PKCα and PICK1 were tested by Western blot.
Results
Results showed that the myocardial fibre necrosis and the higher of lactate dehydrogenase (LDH) in myocardium were found in ADR-induced toxic myocarditis model group. Administration of FSC231 protected the injury of myocardium and reduced the content of LDH. The levels of malondialdehyde in myocardium significantly decreased in FSC231-treated group. The protein expression of PKCα and PICK1 increased in ADR-induced toxic myocarditis model group. Treatment with FSC231 did not reduced the expression of PKCα. Administration of FSC231 failed to reduced the total membrane and cytolic expression of PICK1 but inhibited the increasing membrane expression of PICK1.
Conclusions
These findings indicate that the protective effect of PICK1 on ADR-induced toxic myocarditis is involved in the alleviation of myocardium injury by reducing oxidative stress partially via inhibition of PICK1 protein. This work was supported by the National Nature Science Foundation of China (NSFC) Grant 81000576 to Fei Cai, and NSFC Grant 31000249 to JH Wang, and Foundation of Department of Education of Hubei Province Q20112801, 20112804 to Fei Cai, and Cai-Rong Li
Title: GW24-e3077 Inhibition of PICK1 has the Protective Effect on Adriamycin-induced Toxic Myocarditis
Description:
Objectives
Adriamycin (ADR) has broad-spectrum effect such as anti-tumour and antibiotic, but it is limited the application for its dose-dependent cardiac toxicity.
PICK1 is the interaction protein of PKC, which has been suggested as a potential drug target against brain ischaemia, pain and cocaine addiction.
Our previous study has shown that the expression of PICK1 has increased in ADR-induced toxic myocarditis.
In this study, the possible protect effect of FSC231, the specifical PDZ domain inhibitor of PICK1, against ADR-induced toxic myocarditis were carried out.
Methods
An experimental ADR-induced toxic myocarditis model was induced by intraperitoneal injection of ADR (3mg/kg) one day intervals on 14 consecutive days in mice.
FSC231 (0.
1ml/10g, 25 μM) was administrated by intraperitoneal injection on 14 consecutive days.
At the end of the experiment, mice were sacrificed and their hearts were harvested for marker enzyme, histologic and molecular biologic analysis.
The expression of PKCα and PICK1 were tested by Western blot.
Results
Results showed that the myocardial fibre necrosis and the higher of lactate dehydrogenase (LDH) in myocardium were found in ADR-induced toxic myocarditis model group.
Administration of FSC231 protected the injury of myocardium and reduced the content of LDH.
The levels of malondialdehyde in myocardium significantly decreased in FSC231-treated group.
The protein expression of PKCα and PICK1 increased in ADR-induced toxic myocarditis model group.
Treatment with FSC231 did not reduced the expression of PKCα.
Administration of FSC231 failed to reduced the total membrane and cytolic expression of PICK1 but inhibited the increasing membrane expression of PICK1.
Conclusions
These findings indicate that the protective effect of PICK1 on ADR-induced toxic myocarditis is involved in the alleviation of myocardium injury by reducing oxidative stress partially via inhibition of PICK1 protein.
This work was supported by the National Nature Science Foundation of China (NSFC) Grant 81000576 to Fei Cai, and NSFC Grant 31000249 to JH Wang, and Foundation of Department of Education of Hubei Province Q20112801, 20112804 to Fei Cai, and Cai-Rong Li.
Related Results
Exploring Vimentin's Role in Breast Cancer via PICK1 Alternative Polyadenylation and the miR-615-3p- PICK1 Interaction
Exploring Vimentin's Role in Breast Cancer via PICK1 Alternative Polyadenylation and the miR-615-3p- PICK1 Interaction
Abstract
Background: Breast cancer continues to be a major health issue for women worldwide, with Vimentin (VIM) identified as a crucial factor in its progression due to it...
Integrated Bioinformatics analysis and Metabolomic Responses in finding novel therapeutic approach to treat viral myocarditis
Integrated Bioinformatics analysis and Metabolomic Responses in finding novel therapeutic approach to treat viral myocarditis
Abstract
Background
Myocarditis is one of the most common health problems in young people. Despite imaging...
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges
Abstract
Background
Immune checkpoint inhibitors (ICIs), which are increasingly used in cancer pharmacotherapy, can induce myoca...
Effect of recurrent pregnancies on the evolution of adriamycin nephropathy
Effect of recurrent pregnancies on the evolution of adriamycin nephropathy
Abstract
Background.
In rats with incipient adriamycin nephropathy, pregnancy increases urine protein excretion and mean ...
Evolution of Myocarditis Incidence at a Large Healthcare System Before and During COVID-19 Pandemic
Evolution of Myocarditis Incidence at a Large Healthcare System Before and During COVID-19 Pandemic
Abstract
Background
Myocarditis is a recognized complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Background: Myocarditis and pericarditis cases following Coronavirus 2019 (COVID-19) vaccination were reported worldwide. In Thailand, COVID-19 vaccines were approved for emergency...
P1813Impact of cardiac MRI imaging on detection rates of myocarditis
P1813Impact of cardiac MRI imaging on detection rates of myocarditis
Abstract
Background
The Lake Louise Criteria for the diagnosis of myocarditis by cardiac MRI (CMR) was published in 2009 (JACC A...
Arc/Arg3.1 has an activity-regulated interaction with PICK1 that results in altered spatial dynamics
Arc/Arg3.1 has an activity-regulated interaction with PICK1 that results in altered spatial dynamics
AbstractActivity-regulated cytoskeleton-associated protein (Arc; also known as Arg3.1) is an immediate early gene product that is transcribed in dendritic spines and, to date, has ...

